Press Releases
Pharma Giant AstraZeneca Suing to End Cost-Lowering Program Boasts Nearly $2B in Earnings
AstraZeneca announced nearly $2 billion in Q2 2024 earnings today—a shocking total earned amid the company’s ongoing legal challenge to block the Biden-Harris administration from lowering medication costs for millions of Americans. The pharmaceutical giant is one of five companies appealing recent court rulings defending Medicare’s negotiation auth
